Lineage Cell Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Lineage Cell Therapeutics, Inc. (LCTX) reported Foreign Currency Transaction Gain (Loss), before Tax of $664.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $664.00K, a 60.43% decline year-over-year.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $50.00K.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $482.00K, a 3113.33% increase year-over-year.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $219.00K, a 51.12% decline year-over-year.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was $2.15M.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$269.00K.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$544.00K.
- Lineage Cell Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$2.27M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $664.00K 10-Q · filed 2026-08-06 | $714.00K 10-Q · filed 2026-08-06 | $1.20M derived: sum of 3 quarters · filed 2026-08-06 | $1.42M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $50.00K 10-Q · filed 2026-05-12 | $532.00K derived: sum of 2 quarters · filed 2026-05-12 | $751.00K derived: sum of 3 quarters · filed 2026-05-12 | $2.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $701.00K derived: sum of 2 quarters · filed 2026-03-05 | $2.38M derived: sum of 3 quarters · filed 2026-08-06 | $2.15M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $219.00K 10-Q · filed 2025-11-06 | $1.90M derived: sum of 2 quarters · filed 2026-08-06 | $1.67M 10-Q · filed 2025-11-06 | $1.68M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.68M 10-Q · filed 2026-08-06 | $1.45M 10-Q · filed 2026-08-06 | $1.46M derived: sum of 3 quarters · filed 2026-08-06 | $1.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$231.00K 10-Q · filed 2026-05-12 | -$216.00K derived: sum of 2 quarters · filed 2026-05-12 | $232.00K derived: sum of 3 quarters · filed 2026-05-12 | -$146.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $463.00K derived: sum of 2 quarters · filed 2026-03-05 | $85.00K derived: sum of 3 quarters · filed 2026-03-05 | -$269.00K 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $448.00K 10-Q · filed 2025-11-06 | $70.00K derived: sum of 2 quarters · filed 2025-11-06 | -$284.00K 10-Q · filed 2025-11-06 | $968.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$378.00K 10-Q · filed 2025-08-12 | -$732.00K 10-Q · filed 2025-08-12 | $520.00K derived: sum of 3 quarters · filed 2025-08-12 | -$307.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$354.00K 10-Q · filed 2025-05-13 | $898.00K derived: sum of 2 quarters · filed 2025-05-13 | $71.00K derived: sum of 3 quarters · filed 2025-05-13 | -$426.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $425.00K derived: sum of 2 quarters · filed 2025-03-10 | -$72.00K derived: sum of 3 quarters · filed 2025-03-10 | -$544.00K 10-K · filed 2025-03-10 | -$602.00K 10-K · filed 2024-03-07 | |||
| 2023-09-30 | -$827.00K 10-Q · filed 2024-11-14 | -$1.32M derived: sum of 2 quarters · filed 2024-11-14 | -$1.80M 10-Q · filed 2024-11-14 | -$1.89M 10-Q · filed 2023-11-09 | -$1.40M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$497.00K 10-Q · filed 2024-08-08 | -$969.00K 10-Q · filed 2024-08-08 | -$573.00K derived: sum of 3 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | -$472.00K 10-Q · filed 2024-05-09 | -$76.00K derived: sum of 2 quarters · filed 2024-05-09 | ||||||
| 2022-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$2.27M 10-K · filed 2024-03-07 | ||||||
| 2022-09-30 | -$2.67M 10-Q · filed 2023-11-09 | |||||||
| 2015-09-30 | -$430.00K 10-Q · filed 2015-11-09 | -$147.00K derived: sum of 2 quarters · filed 2015-11-09 | -$353.00K 10-Q · filed 2015-11-09 | -$106.07K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2015-06-30 | $283.00K 10-Q · filed 2015-08-10 | $77.00K 10-Q · filed 2015-08-10 | $323.93K derived: sum of 3 quarters · filed 2015-08-10 | $235.93K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2015-03-31 | -$205.15K 10-Q · filed 2015-05-08 | $40.93K derived: sum of 2 quarters · filed 2015-05-08 | -$47.07K derived: sum of 3 quarters · filed 2015-11-09 | $104.93K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2014-12-31 | $246.08K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $158.08K derived: sum of 2 quarters · filed 2015-11-09 | $310.08K derived: sum of 3 quarters · filed 2015-11-09 | $338.08K 10-K · filed 2015-03-11 | ||||
| 2014-09-30 | -$88.00K 10-Q · filed 2015-11-09 | $64.00K derived: sum of 2 quarters · filed 2015-11-09 | $92.00K 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | $152.00K 10-Q · filed 2015-08-10 | $141.00K 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$10.21K 10-Q · filed 2015-05-08 | $10.21K 10-Q · filed 2014-05-12 | ||||||
| 2013-12-31 | $133.48K 10-K · filed 2015-03-11 | |||||||
| 2013-06-30 | $28.86K 10-Q · filed 2014-08-11 | -$92.46K 10-Q · filed 2013-08-09 | $177.29K 10-Q · filed 2014-08-11 | -$115.15K 10-Q · filed 2013-08-09 | $45.14K derived: sum of 3 quarters · filed 2014-08-11 | $79.77K derived: sum of 4 quarters · filed 2014-08-11 | ||
| 2013-03-31 | $21.98K 10-Q · filed 2014-05-12 | $16.28K derived: sum of 2 quarters · filed 2014-05-12 | $50.91K derived: sum of 3 quarters · filed 2014-05-12 | $154.38K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | -$5.70K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $28.93K derived: sum of 2 quarters · filed 2014-03-17 | $132.41K derived: sum of 3 quarters · filed 2014-03-17 | $34.23K 10-K · filed 2014-03-17 | ||||
| 2012-09-30 | $34.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $138.10K derived: sum of 2 quarters · filed 2013-08-09 | $39.93K 10-Q · filed 2012-11-09 | $157.96K derived: sum of 4 quarters · filed 2013-08-09 | ||||
| 2012-06-30 | $103.47K 10-Q · filed 2013-08-09 | $5.30K 10-Q · filed 2013-08-09 | $5.31K 10-Q · filed 2012-08-09 | $123.33K derived: sum of 3 quarters · filed 2013-08-09 | $819.99K derived: sum of 4 quarters · filed 2013-08-09 | |||
| 2012-03-31 | $95.80K 10-Q · filed 2013-05-10 | $124.09K 10-Q · filed 2012-05-10 | $19.85K derived: sum of 2 quarters · filed 2013-05-10 | $716.51K derived: sum of 3 quarters · filed 2013-05-10 | -$212.02K derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | -$75.94K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $620.72K derived: sum of 2 quarters · filed 2013-03-18 | -$307.82K derived: sum of 3 quarters · filed 2013-03-18 | $14.83K 10-K · filed 2013-03-18 | -$1.02M 10-K · filed 2012-03-14 | |||
| 2011-09-30 | $696.66K 10-Q · filed 2011-11-08 | -$231.88K derived: sum of 2 quarters · filed 2011-11-08 | $90.77K 10-Q · filed 2012-11-09 | -$901.88K 10-Q · filed 2011-11-08 | -$2.18K derived: sum of 4 quarters · filed 2012-05-10 | |||
| 2011-06-30 | -$928.54K 10-Q · filed 2011-08-09 | -$163.36K 10-Q · filed 2012-08-09 | -$1.60M 10-Q · filed 2011-08-09 | -$698.84K derived: sum of 3 quarters · filed 2012-05-10 | -$695.29K derived: sum of 4 quarters · filed 2012-05-10 | |||
| 2011-03-31 | -$670.00K 10-Q · filed 2012-05-10 | $229.70K derived: sum of 2 quarters · filed 2012-05-10 | $233.24K derived: sum of 3 quarters · filed 2012-05-10 | $227.33K derived: sum of 4 quarters · filed 2012-05-10 | ||||
| 2010-12-31 | $899.70K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $903.25K derived: sum of 2 quarters · filed 2012-03-14 | $897.34K derived: sum of 3 quarters · filed 2012-03-14 | $897.34K 10-K · filed 2012-03-14 | ||||
| 2010-09-30 | $3.55K 10-Q · filed 2011-11-08 | -$2.36K derived: sum of 2 quarters · filed 2011-11-08 | -$2.36K 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | -$5.91K 10-Q · filed 2011-08-09 | -$5.91K 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |